Relmada TherapeuticsRLMD

13F holders, Q1 2025 (March 31)
44holders −4
7new positions
12sold out
1famous investor
$0.27avg. 13F price*

At the end of Q1 2025, 44 institutions reported holding Relmada Therapeutics Inc. (RLMD) in their 13F filings, down 4 from Q4 2024. 7 opened new positions and 12 sold out. The largest holders were Acadian Asset Management LLC ($329K), Vanguard Group Inc. ($326K) and BlackRock, Inc. ($153K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Relmada Therapeutics Inc.
CUSIP
75955J402
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 93Q1 2024Q2 2024: 79Q2 2024Q3 2024: 69Q3 2024Q4 2024: 48Q4 2024Q1 2025: 44Q1 2025Q2 2025: 50Q2 2025Q3 2025: 44Q3 2025Q4 2025: 78Q4 2025Q1 2026: 103Q1 2026Q2 2026: 126Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions7$59K
Exits12$393K

All 13F filers, Q4 2024 → Q1 2025: 418,999 shares bought and 2,618,732 shares sold, net −2,199,733 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 44 holders

Acadian Asset Management LLC 0.00% No change 1,227,928 $329K
Vanguard Group Inc. 0.00% Reduce -3.9% 1,208,075 $326K
BlackRock, Inc. 0.00% Reduce -4.5% 566,905 $153K
Palo Alto Investors LP 0.03% No change 495,146 $134K
Geode Capital Management, LLC 0.00% Reduce -0.3% 301,883 $82K
Two Sigma Advisers, LP 0.00% Add +44.8% 288,000 $78K
AdvisorShares Investments LLC 0.01% Add +31.6% 276,514 $76K
Deutsche Bank AG 0.00% No change 224,846 $61K
Two Sigma Investments, LP 0.00% Add +33.7% 170,544 $46K
Parsons Capital Management Inc. 0.00% No change 163,336 $44K
RBF Capital, LLC 0.00% No change 163,261 $44K
UBS Group AG 0.00% Reduce -32.7% 144,789 $39K
Renaissance Technologies 0.00% Reduce -24.6% 124,100 $34K
Goldman Sachs Group Inc. 0.00% New 120,852 $33K
State Street Corp. 0.00% No change 106,735 $29K
Mgo One Seven LLC 0.00% No change 100,000 $27K
Northern Trust Corp. 0.00% Reduce -29.3% 59,571 $16K
HRT Financial LP 0.00% New 52,043 $14K
apricus wealth, LLC 0.01% No change 48,962 $13K
Franklin Resources Inc. 0.00% Reduce -96.7% 42,797 $12K
Ikarian Capital, LLC 0.00% No change 40,270 $11K
Sei Investments Co. 0.00% No change 36,230 $10K
AlTi Global, Inc. 0.00% No change 31,975 $9K
Group One Trading LLC 0.00% Reduce -71.9% 28,641 $8K
Wealthedge Investment Advisors, LLC 0.00% No change 28,000 $8K
Robertson Stephens Wealth Management, LLC 0.00% No change 25,000 $7K
Tortoise Investment Management, LLC 0.00% No change 21,676 $6K
World Investment Advisors 0.00% Reduce -27.1% 21,644 $6K
Pandora Wealth, Inc. 0.00% — 20,000 $5K
Two Sigma Securities, LLC 0.00% New 14,012 $4K
Lido Advisors, LLC 0.00% New 13,905 $4K
Bank of America Corp. 0.00% Reduce -93.4% 13,716 $4K
StoneX Group Inc. 0.00% New 13,234 $4K
Bedel Financial Consulting, Inc. 0.00% No change 10,000 $4K
Hexagon Capital Partners LLC 0.00% No change 4,000 $1K
American Capital Advisory, LLC 0.00% Add +100.0% 3,908 $1K
Simplex Trading, LLC 0.00% New 4,482 $1K
Morgan Stanley 0.00% Reduce -87.4% 2,168 $585
JPMorgan Chase & Co. 0.00% Reduce -99.6% 158 $43
SBI Securities Co., Ltd. 0.00% No change 102 $28
BNP Paribas Financial Markets 0.00% No change 72 $19
Front Row Advisors LLC 0.00% New 6 $2
Citigroup Inc. 0.00% Reduce -100.0% 2 $1
Osaic Holdings, Inc. 0.00% Reduce -84.4% 5 $1

"% of holder's portfolio" is RLMD's weight in each manager's 13F, not the share of Relmada Therapeutics Inc. the manager owns.